Firms

Redalpine

Zurich, CH

redalpine.com

signal.nfx.com

goldi.ai

Redalpine is a pan-European venture capital firm with Swiss roots, founded in 2006 and headquartered in Zurich. It invests at the intersection of software and science, targeting companies from seed through growth stages across sectors including AI, biotech, fintech, energy, and health.

Founded: —
Type: Venture capital

Funds3

Redalpine Capital VIII2025-102025-10—
CHF 200m target; distributor lists October 2025 first close and expected Q1 2026 final close, no achieved final amount verified. Deployment supported by 2026 microagi announcement. Date reflects first-close month claim, not final close.
Redalpine Capital VII2024-08-272024-08-27$200M
Final close oversubscribed; sixth early-stage fund despite VII name. No AUM conflation.
Summit Fund20202020—
Evergreen semi-liquid seed to pre-IPO strategy, Redalpine adviser and Gimpel Private Markets manager. CHF 1bn industry listing is not verified NAV/closed amount.

Team

Michael Sidler Redalpine, partner	$2M$500K – $5M	Europe
Nadine Geiser Redalpine, investor	$2M$500K – $5M	Munich, Germany
Oliver Pabst Redalpine, general_partner	$2M$500K – $5M	Switzerland
Aleksandra Laska Redalpine, partner	$2M$500K – $5M	Zurich, Switzerland
Daniel Dillinger Redalpine, investor	$2M$500K – $5M	Zurich, Switzerland
Désirée Reimann Redalpine, general_partner	$2M$500K – $5M	Zurich, Switzerland
Harald Nieder Redalpine, general_partner	$2M$500K – $5M	Zurich, Switzerland
Marc Lübke Redalpine, unknown	$2M$500K – $5M	Zurich, Switzerland
Peter Niederhauser Redalpine, partner	$2M$500K – $5M	Zurich, Switzerland
Sebastian Becker Redalpine, general_partner	$2M$500K – $3M	Zurich, Switzerland
Daniel Graf Redalpine, General Partner	—— – —
Lezama Schneider Redalpine, Principal	—— – —
Mira Kamp Redalpine, Principal & Managing Director	—— – —
Violet Greene Redalpine, Growth Equity	—— – —

Investments

team@apexlogos.ai15 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities. Fund sizes and current stages | Vehicle/metric | Amount and status | Date and supporting evidence | |---|---|---| | Redalpine Capital VII / RAC VII | **US$200 million final close**, oversubscribed. Officially called its sixth early-stage fund despite the VII name. | Firm-issued [GlobeNewswire announcement](https://www.globenewswire.com/news-release/2024/08/27/2936144/0/en/redalpine-closes-largest-fund-to-date-200m-rac-vii-and-announces-new-london-office.html), 2024-08-27; [firm post](https://www.redalpine.com/post/introducing-rac-vii-and-our-london-expansion), 2024-08-27, updated 2025-01-20. | | RAC VIII | **CHF200 million target**, newer vehicle. Distributor lists first closing October 2025 and expected final closing Q1 2026, but no achieved final amount was verified. Its deployment is corroborated by the firm's 2026 microagi announcement. | [Agathon Capital product page](https://www.agathon-capital.de/investmentfonds/redalpine-capital-viii), undated/accessed 2026-10-06; [firm July newsletter](https://www.redalpine.com/post/welcome-to-our-july-newsletter-1), displayed Aug 3, indexed 2026. Planned closing text may now be stale. | | Summit Fund | Evergreen, semi-liquid, multi-stage; launched 2020. **CHF1 billion** appears in the 2026 industry report's fund listing but is not verified here as actual fund NAV or a closed commitment total. | [Firm Summit strategy](https://www.redalpine.com/summitfund), undated/accessed 2026-10-06; [2026 Swiss VC report](https://allnews.ch/sites/default/files/ckfinder/userfiles/VCReport_2026_web.pdf), 2026, search-index evidence. Treat the listed amount conservatively pending report-footnote/fund-factsheet review. | | RAG | 2026 report lists **CHF400 million**, growth/Series B onward; close versus fundraising status unresolved. | Same [2026 Swiss VC report](https://allnews.ch/sites/default/files/ckfinder/userfiles/VCReport_2026_web.pdf), search-index evidence only; no primary final-close announcement verified. | | Firm AUM | **>$1 billion** across seven funds in August 2024; homepage now says **$1.4 billion+**, eight total funds. Neither is an individual fund size. | 2024 release above; [homepage](https://www.redalpine.com/), undated/accessed 2026-10-06. | The [official Summit strategy page](https://www.redalpine.com/summitfund), undated/accessed 2026-10-06, specifies initial early-stage investments at **pre-seed through Series A**, while Summit invests **seed to pre-IPO** through early-stage fund commitments and direct company investments. It identifies Redalpine as advisor and Gimpel Private Markets as Summit manager. Agathon's RAC VIII description supports seed/early-stage and a 16–20-company intended portfolio, with 40–50% reserved for follow-ons. Later-stage transactions demonstrate follow-on capacity but do not turn every Redalpine fund into a growth-only fund. Newer funds were actively searched; RAC VII is the latest verified final-close amount in this research, not necessarily the firm's latest fund. Funds recorded in Adex after this review: | Fund | Disclosed amount | Announcement / filing date | | --- | --- | --- | | Summit Fund | Undisclosed / unverified | 2020 | | Redalpine Capital VII | USD 200000000 | 2024-08-27 | | Redalpine Capital VIII | Undisclosed / unverified | 2025-10 |
team@apexlogos.ai16 hours ago
Match research 2026-10-06 / Redalpine / sha256:92de3c88660ee08d3c99b6ddb9c80858a6fd53fd33c0d8a50aca11ff8560315e / part 2 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. | **microagi** | Deployment/adaptation of embodied models and robotics for factories; deep-tech classification rests on robotics and physical-world model integration, with a less clear proprietary hardware barrier than fusion/propulsion. Redalpine attributes its **$55m seed** participation to RAC VIII; Hummingbird led. | [Firm July newsletter](https://www.redalpine.com/post/welcome-to-our-july-newsletter-1), displayed August 3, indexed 2026; precise round announcement day not established. | This is a verified, relevant selection, not an exhaustive independently rechecked transaction ledger. Araris, Hypervision, Apoha and microagi round details rely on the investing firm's own statements; those are primary attribution but are not independent confirmation by the investee. Proxima and Flexion have directly read investee announcements. ## Neurotech findings and boundaries **No verified neurotech investment found in the sources checked.** Checked the saved investment list, NFX firm/partner profiles, current official portfolio, and searches for Redalpine combined with neurotech/neurotechnology, brain, EEG and MindMaze. Searches produced general neurotech results without establishing Redalpine's investment in MindMaze; no such attribution is made. Apoha's [“liquid brain” and neuron-like molecular behavior](https://www.redalpine.com/portfolio/apoha) supports brain-inspired computing language, not a verified neural interface, brain sensing or stimulation product. It is recorded as deep tech with a possible broad neuromorphic adjacency, not direct neurotechnology. Flexion's “brain” is the robot control stack, not human neural measurement. Hypervision's surgical imaging is general medtech; neurosurgical applicability alone would not establish a neurotech mandate. Araris is oncology drug-delivery biotech, and Hilo/Level Zero are physiological biosensing, not evidenced neural sensing. Undated technology pages accessed 2026-10-06. ## Conflicts, missing information and later Adex review 1. Preserve exact firm ID `Redalpine`; distinguish branded firm/advisor from individual Luxembourg fund vehicles and Summit's separate manager. Correct founding only after reviewing the 2006 firm versus 2007 first-fund difference; Signal Munich should not override Zurich-origin evidence. 2. Record RAC VII $200m closed separately from RAC VIII CHF200m target, aggregate AUM and Summit's report figure. Verify RAC VIII final-close amount/date and RAG fundraising status with current primary materials. A scheduled Q1 2026 close is not proof it occurred. 3. Review snapshot aliases and duplicate participations: Proxima/Proxima Fusion/PROXIMA FUSION GMBH; Flexion/Flexion Robotics; Araris/Araris Biotech; Dalton/DaltonTx; Luya/Luya Foods. Duplicate names do not represent separate companies by default. 4. Snapshot attaches the July 2026 Proxima €411m article to a seed entry with year-only date. Official article gives 2026-07-07 and no seed label. Preserve the distinct June 2025 €130m Series A and 2024 seed. 5. Flexion snapshot contains $7.35m as a participation amount. Company identifies that as the entire seed round, so no Redalpine check amount can be inferred. [Firm November post](https://www.redalpine.com/post/building-the-mechanical-knight), 2025-11-20, calls it a $57m round, while company separates $50m Series A and $7.35m seed. Prefer the disaggregated company account; $57m appears rounded cumulative financing. 6. Snapshot lists Apoha seed in 2024 and a 2026 seed row; firm's investment account says first backing in 2023 and identifies the newer $36m as Series A. Review exact original seed announcement rather than carrying over imported stages. 7. Current check policy, exact vehicle attribution for every historic participation, individual investor allocations and comprehensive neurotechnology exposure remain unverified. Do not fill these from Signal's stale profile or total round values. Ordinary SaaS and fintech holdings should retain their proper categories. All linked sources were accessed 2026-10-06; publication dates are provided above when visible. No Adex/database update, MCP Patch or commit was made.
team@apexlogos.ai16 hours ago
Match research 2026-10-06 / Redalpine / sha256:92de3c88660ee08d3c99b6ddb9c80858a6fd53fd33c0d8a50aca11ff8560315e / part 1 of 2 Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats. # Redalpine - Exact Adex ID: `Redalpine` - Adex webpage: https://adex.page/firms/Redalpine - Research date: 2026-10-06 - Status: completed research; unresolved items explicitly retained for review. Redalpine is a European investment advisor with Swiss roots, established in 2006, investing across software and science. It has directly evidenced investments in fusion, spacecraft propulsion, robotics, molecular measurement, antibody engineering and surgical imaging. Its early-stage strategy and Summit's broader mandate make stage attribution vehicle-specific. No verified neurotech investment found in the sources checked. [Official homepage, undated, accessed 2026-10-06](https://www.redalpine.com/). ## Starting evidence: Adex and NFX Signal The exact-ID saved MCP Search record, `data/research/_sources/Redalpine.adex.json`, retrieved 2026-10-06, identifies Zurich-based Redalpine and links its website, Signal and Goldi. It contains 110 investment participations, 14 team roles, and no check minimum, maximum or sweet spot. These are baseline claims, not independent verification. Selected existing deep-tech leads include Proxima Fusion, Magdrive, Flexion, Araris, Apoha, Hypervision Surgical, Dunia and Basecamp Research. The snapshot also includes ordinary software, fintech and marketplaces, which should not receive a blanket deep-tech label. [NFX firm profile](https://signal.nfx.com/firms/redalpine-venture-partners), directly read, undated/accessed 2026-10-06, describes seed/early-stage tech and healthtech, approximately $1 billion AUM, first fund in 2007 and sixth fund closed in 2021. It labels founding as 2007 and Munich as primary location while also listing Zurich/Switzerland. Official firm history instead says 2006/Zurich: first-fund vintage may explain the year discrepancy, but Munich requires review. The public firm-team section was empty in the retrieved text. [Peter Niederhauser's Signal profile](https://signal.nfx.com/investors/peter-niederhauser), directly read, undated/accessed 2026-10-06, lists partner affiliation, $500,000–$5 million range, $2.5 million sweet spot and $80 million current fund size; its rankings include biotech seed and Series A. These are individual profile fields with no fund vintage or verification date, and $80 million conflicts with newer official funds. Do not use them as current firm-wide check policy. Intro/network information requires Google sign-in; no sign-in performed. ## Fund sizes and current stages | Vehicle/metric | Amount and status | Date and supporting evidence | |---|---|---| | Redalpine Capital VII / RAC VII | **US$200 million final close**, oversubscribed. Officially called its sixth early-stage fund despite the VII name. | Firm-issued [GlobeNewswire announcement](https://www.globenewswire.com/news-release/2024/08/27/2936144/0/en/redalpine-closes-largest-fund-to-date-200m-rac-vii-and-announces-new-london-office.html), 2024-08-27; [firm post](https://www.redalpine.com/post/introducing-rac-vii-and-our-london-expansion), 2024-08-27, updated 2025-01-20. | | RAC VIII | **CHF200 million target**, newer vehicle. Distributor lists first closing October 2025 and expected final closing Q1 2026, but no achieved final amount was verified. Its deployment is corroborated by the firm's 2026 microagi announcement. | [Agathon Capital product page](https://www.agathon-capital.de/investmentfonds/redalpine-capital-viii), undated/accessed 2026-10-06; [firm July newsletter](https://www.redalpine.com/post/welcome-to-our-july-newsletter-1), displayed Aug 3, indexed 2026. Planned closing text may now be stale. | | Summit Fund | Evergreen, semi-liquid, multi-stage; launched 2020. **CHF1 billion** appears in the 2026 industry report's fund listing but is not verified here as actual fund NAV or a closed commitment total. | [Firm Summit strategy](https://www.redalpine.com/summitfund), undated/accessed 2026-10-06; [2026 Swiss VC report](https://allnews.ch/sites/default/files/ckfinder/userfiles/VCReport_2026_web.pdf), 2026, search-index evidence. Treat the listed amount conservatively pending report-footnote/fund-factsheet review. | | RAG | 2026 report lists **CHF400 million**, growth/Series B onward; close versus fundraising status unresolved. | Same [2026 Swiss VC report](https://allnews.ch/sites/default/files/ckfinder/userfiles/VCReport_2026_web.pdf), search-index evidence only; no primary final-close announcement verified. | | Firm AUM | **>$1 billion** across seven funds in August 2024; homepage now says **$1.4 billion+**, eight total funds. Neither is an individual fund size. | 2024 release above; [homepage](https://www.redalpine.com/), undated/accessed 2026-10-06. | The [official Summit strategy page](https://www.redalpine.com/summitfund), undated/accessed 2026-10-06, specifies initial early-stage investments at **pre-seed through Series A**, while Summit invests **seed to pre-IPO** through early-stage fund commitments and direct company investments. It identifies Redalpine as advisor and Gimpel Private Markets as Summit manager. Agathon's RAC VIII description supports seed/early-stage and a 16–20-company intended portfolio, with 40–50% reserved for follow-ons. Later-stage transactions demonstrate follow-on capacity but do not turn every Redalpine fund into a growth-only fund. Newer funds were actively searched; RAC VII is the latest verified final-close amount in this research, not necessarily the firm's latest fund. ## Verified previous deep-tech investments Amounts below are total company financing rounds, not Redalpine's checks. Attribution is to the firm/fund, not a partner's prior employer. | Company | Technology and investment evidence | Dated supporting URLs | |---|---|---| | **Proxima Fusion** | Stellarator fusion engineering and high-temperature superconducting magnets. Redalpine led the 2024 seed and participated in the **€130m Series A** in 2025. Returned for the **€411m financing** in 2026; the latter is not labeled seed in the official announcement. | [Company Series A announcement](https://www.proximafusion.com/press-news/proxima-fusion-raises-eu130m-series-a-to-build-worlds-first-stellarator-based-fusion-power-plant-in-the-2030s), 2025-06-11; [company €411m announcement](https://www.proximafusion.com/press-news/proxima-fusion-raises-eu411-million-to-build-europes-commercial-fusion-champion), 2026-07-07. | | **Magdrive** | Electric/plasma spacecraft propulsion using solid-metal propellant: clear physics/hardware research dependency. Redalpine says it led **$10.5m seed**, RAC VII, announced in its February roundup. Investee displays Redalpine among backers. | [Firm newsletter](https://www.redalpine.com/post/welcome-to-our-february-newsletter), 2025-03-04; [company about/backers](https://magdrive.space/about-us/), undated/accessed 2026-10-06. | | **Flexion** | Reinforcement learning, simulation-to-real transfer and whole-body humanoid robot control. Company names Redalpine in **$50m Series A**, following **$7.35m seed** with Redalpine a few months earlier. Firm portfolio identifies RAC VII and investment year 2025. | [Company announcement](https://flexion.ai/news/flexion-raises-50m-to-build-the-brain-of-humanoid-robots-at-scale), 2025-11-20; [firm portfolio](https://www.redalpine.com/portfolio/flexion), undated/accessed 2026-10-06. | | **Araris Biotech** | Antibody-drug conjugate linker platform designed for stable, targeted delivery: scientific biotech rather than ordinary SaaS. Redalpine Capital IV significantly participated in the **CHF15.2m seed** led by Pureos. | [Firm announcement](https://www.redalpine.com/post/araris-raises-chf-15-2-million-seed-financing-for-a-novel-generation-of-antibody-therapeutics), 2020-10-22. | | **Hypervision Surgical** | AI-assisted hyperspectral tissue imaging for intraoperative margins and surgical guidance. Redalpine **co-led £6.5m seed**, RAC VI, with HERAN Partners, LifeX Ventures and ZEISS Ventures. | [Firm announcement](https://www.redalpine.com/post/hypervision-surgical-raises-6-5m-seed-to-improve-surgical-precision), 2023-06-01, updated 2025-02-03; [firm portfolio](https://www.redalpine.com/portfolio/hypervision-surgical), accessed 2026-10-06. | | **Apoha** | Novel molecular-behavior measurement/biophysics and machine intelligence; portfolio describes neuron-like dynamics within complex molecules. Redalpine says it first backed the **2023 seed**, and continued in **$36m Series A** led by Singular. Exact seed amount/date not verified. | [Firm investment account](https://www.redalpine.com/post/apoha-unlocking-the-missing-data-class-of-molecular-science), displayed June 24, indexed 2026; [portfolio description](https://www.redalpine.com/portfolio/apoha), undated/accessed 2026-10-06. |
team@apexlogos.ai23 days ago
MATCH

€411M2026-07-07	PROXIMA FUSION GMBH	Lightspeed, Burda Principal Investments, Cherry Ventures, UVC Partners, SPRIND, Bayern Kapital, Balderton Capital, Elaia, Redalpine
€411M2026-07-07	Proxima Fusion	Lightspeed, DCVC, Burda Principal Investments, Plural Platform, UVC Partners, SPRIND, Balderton Capital, Cherry Ventures, Elaia, Plural, Redalpine
$—2026-03-31	9Fin	Redalpine
$36M2026	Apoha	Redalpine
$10M2026	Helical	BoxGroup, Gradient Ventures, Redalpine
$50M2025-11-20	Flexion	Redalpine
$50M2025-11-20	Flexion	Redalpine
$12M2025-11-18	Albatross	MMC Ventures, Redalpine
$50M2025-11-17	Voize	Y Combinator, Redalpine, Balderton Capital, HV Capital, Felix Klühr, Daniel Waterhouse
$12M2025-10-20	Valink Therapeutics	Redalpine, Michael Sidler
$—2025-09-24	Synthesized	Redalpine, IQ Capital
$—2025-09-23	Dalton	Redalpine, IQ Capital
$—2025-06-24	Lyceum	Redalpine, 10x Founders
$31M2025-06-13	Knowunity	PortfoLion Capital Partners, Project A Ventures, Redalpine, Anton Waitz
€130M2025-06-11	PROXIMA FUSION GMBH	Cherry Ventures, Balderton Capital, Lightspeed, Elaia, UVC Partners, Bayern Kapital, Club degli Investitori, HTGF, DeepTech & Climate Fonds, Plural, Leitmotif, Omnes Capital, Visionaries Tomorrow, Wilbe, Redalpine
€130M2025-06-11	Proxima Fusion	Cherry Ventures, Balderton Capital, Lightspeed, Plural Platform, UVC Partners, Bayern Kapital, Club degli Investitori, Elaia, Plural, Redalpine, Ian Hogarth, Daniel Waterhouse, Filip Dames
$42M2025-05-02	Hilo (formerly Aktiia)	Earlybird Health, Wellington Partners, Kfund, naturalX Health Ventures, Redalpine, Khosla Ventures, Molten Ventures, Translink Capital, Verve Ventures
$—2025-05-02	Aktiia (rebranding to Hilo)	Khosla Ventures, Wellington Management, Motier Ventures, Redalpine, Translink Capital, naturalX Health Ventures
$42M2025-05-01	Hilo	Khosla Ventures, Wellington Management, Motier Ventures, Redalpine, Translink Capital, naturalX Health Ventures, Christoph Massner, Michael Sidler
$9M2025-03-31	Voize	Y Combinator, Redalpine, HV Capital, pi Ventures, Felix Klühr
$10M2025-02-25	Magdrive	Redalpine, Founders Fund, Alumni Ventures, 7percent Ventures, Courtside Ventures, Entrepreneurs First
$—2025-02-18	level zero	Redalpine
$—2024-12-02	9Fin	Redalpine
$—2024-10-16	Albatross	Redalpine
$60M2024-10-09	Basecamp	S32, Singular, Redalpine, Section 32
$—2024-07-24	Lakera	Atomico, Fly Ventures, Inovia Capital, Redalpine
$16M2024-07-15	LegalFly	Notion Capital, Redalpine
$—2024-05-07	Memo Therapeutics	Redalpine
$—2024-04-10	Proxima Fusion	Redalpine, Plural
$37M2024-02-26	Inkitt	Khosla Ventures, Vinod Khosla, Kleiner Perkins, New Enterprise Associates, Redalpine, oliver holle, Harald Nieder
$—2024-01-25	Infinite Roots	Redalpine
$—2024	Apoha	Redalpine
$—2024	Dunia	Elaia, Kindred Ventures, Redalpine
$60M2024	Basecamp Research	S32, Singular, Redalpine, True Ventures, Section 32
$—2023-06-08	Uncommon	Redalpine
£6M2023-06-01	Hypervision Surgical	Redalpine
$—2023-04-17	Razor Group	468 Capital, Redalpine
$—2023-03-29	Genialis	Redalpine, Taiwania Capital
$25M2022-07-08	011h	Redalpine, Breega, Benoit Marrel, Harald Nieder
$—2022-06-23	Enviria	Redalpine
$11M2022-05-24	Knowunity	Project A Ventures, Redalpine, Anton Waitz
$220M2022-04-27	Taxfix	Creandum, Redalpine, Index Ventures, Ontario Teachers' Pension Plan, Valar Ventures
$25M2022-02-28	Better Dairy	Redalpine, Nadine Geiser
$—2022	Araris Biotech	Redalpine
$—2021-12-16	Kenbi	Redalpine
$—2021-11-08	Razor Group	468 Capital, Redalpine
$10M2021-10-13	9Fin	Redalpine, Fly Ventures
$59M2021-10-04	Inkitt	HV Capital, Speedinvest, Kleiner Perkins, NEA (New Enterprise Associates), New Enterprise Associates, Redalpine, Axel Springer, Jan Miczaika, Eric Bovee, oliver holle, Harald Nieder
$2M2021-06-22	Donut	Compound, Redalpine, NVentures
$—2021-05-04	Razor Group	Founders Fund, FJ Labs, Victory Park Capital Advisors, LLC, 468 Capital, Redalpine, BlackRock Private Equity Partners
$—2021-02-09	Lengoo	Redalpine
$—2021	Luya	Redalpine
$—2021	Kenbi	Redalpine
$—2021	apaleo	Force Over Mass Capital, Redalpine
$—2021	Morressier	Cherry Ventures, Redalpine
$—2020-12-01	Vivenu	Redalpine
CHF 15M2020-10-22	Araris Biotech	Redalpine
$—2020-05-13	Zenjob	Redalpine
$65M2020-04-16	Taxfix	Creandum, Redalpine, Index Ventures, Valar Ventures
$—2020	Kenjo	Redalpine
$25M2019-09-30	Bnext	Redalpine, Speedinvest, Kaya VC
$16M2019-08-28	Inkitt	Earlybird Venture Capital, Speedinvest, Redalpine, Kleiner Perkins, Xploration Capital, Notion Capital, Jan Miczaika, Eric Bovee, oliver holle, Harald Nieder
$—2019-04-04	Taxfix	Creandum, Redalpine, Valar Ventures
$—2018-12-19	Morressier	Cherry Ventures, Redalpine
CHF 9M2018-09-24	TOLREMO Therapeutics AG	Altos Venture AG, Redalpine
$13M2018-08-09	Taxfix	Creandum, Redalpine, Valar Ventures
$—2017-12-14	Finiata	Point Nine Capital, Kaya VC, Kulczyk Investments, Fly Ventures, DNS Capital, Redalpine
$—2017-09-14	Zenjob	Redalpine
$—2017	bexio	Redalpine
$16M2016-06-21	JUNIQE	Redalpine, Peter Niederhauser
$—2015-10-26	Knip	Redalpine
$—2015	bexio	Redalpine
$—2015	CarThrottle	Redalpine
$—2013-08-19	TrekkSoft	Redalpine
$—Unknown date	Luya Foods	Redalpine
$—Unknown date	Kenjo	Redalpine
$—Unknown date	Luya	Redalpine
$—Unknown date	Forgis	Redalpine
$—Unknown date	Magaloop	Redalpine
$—Unknown date	BiognoSYS	Redalpine
$—Unknown date	BiognoSYS	Redalpine
$—Unknown date	BiognoSYS	Redalpine
$—Unknown date	Lunaphore	Redalpine
$—Unknown date	Lunaphore	Redalpine
$—Unknown date	Lunaphore	Redalpine
$—Unknown date	Daedalean	Redalpine
$—Unknown date	ExpressionEdits	Redalpine
$—Unknown date	felmo	Redalpine
$—Unknown date	apaleo	Redalpine
$36MUnknown date	Apoha	Redalpine
$—Unknown date	N26	Redalpine
$1MUnknown date	Whaly	Y Combinator, Redalpine, Kima Ventures
$10MUnknown date	Magdrive	Redalpine, Founders Fund, Alumni Ventures, 7percent Ventures, Entrepreneurs First, Courtside Ventures
$50M2025-11-20	Flexion Robotics	Moonfire Ventures, Redalpine
$—2025-09-23	DaltonTx	Redalpine
$—2025-06-26	Dejablue	Redalpine
$—2025	DaltonTx	Redalpine
$11M2024-10-23	Dunia Innovations GmbH	Elaia, Redalpine, Kindred Ventures
$12M2024	Albatross AI	MMC Ventures, Redalpine
$—2021	Collato	Redalpine
CHF 15M2020-10-22	Araris	Redalpine
$—2019-04-26	RosieReality	Redalpine
$—2017	Tolremo	Altos Ventures, Redalpine
$—Unknown date	Tolremo	Redalpine
$—Unknown date	Umiami	Redalpine
$7MUnknown date	Flexion Robotics	Redalpine
$—Unknown date	Biolux	Redalpine
$—Unknown date	Valink	Redalpine
$—Unknown date	Versantis	Redalpine
$—Unknown date	Helical AI	Redalpine

Funds3

Team

Co-investing

Investments